MIR342 and B-cell non-Hodgkin lymphoma: Epigenetic silencing of MIR342 and its host gene EVL by DNA methylation was reported in colorectal cancer (13, 24, 25), multiple myeloma (26), and B cell lymphoma (27) from the patients.